MapLight Therapeutics' Alzheimer's Psychosis Drug Granted FDA Fast Track Status
(RTTNews) - MapLight Therapeutics, Inc. (MPLT) on Monday said the U.S. Food and Drug Administration has granted Fast Track designation to ML-007C-MA for the treatment of hallucinations and delusions...
Nasdaq News: Markets·3mo ago